Dilution of Per-Share Value from the Exercise of Stock Acquisition Rights
First written in FY2019. 8 of 12 entries say "Materialised", first in FY2020-Q1. Latest entry: FY2023.
PBsystems moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
53 other companies' latest entry also says "Mitigated".
- FY2023MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by stock acquisition rights was 119,200 (119,200 as of 30 November 2023), equivalent to 1.8% of the 6,583,500 shares issued and outstanding.」
Although 190,400 shares represented by stock acquisition rights were exercised during the fiscal year, the remaining number of potential shares was 119,200, and their ratio to total shares issued and outstanding declined to 1.8%. - FY2023-Q3MaterialisedAnnual report
「In addition, the issuance of new shares through the exercise of stock acquisition rights increased stated capital and the capital surplus by ¥11.995 million each.」
The exercise of stock acquisition rights resulted in the issuance of 95,200 shares, increasing total shares issued and outstanding from 6,488,300 to 6,583,500. An increase in the number of shares that could lead to dilution actually occurred. - FY2023-Q1MaterialisedAnnual report
「25 October 2022 95,200 6,488,300 5,997 344,267 5,997 344,267 Exercise of stock acquisition rights (stock options)」
The exercise of stock acquisition rights resulted in the issuance of 95,200 shares, increasing total shares issued and outstanding from 6,152,800 to 6,488,300. - FY2022MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by these stock acquisition rights was 309,600 (214,400 as of 30 November 2022), equivalent to 5.0% of the 6,152,800 shares issued and outstanding (as of 30 November 2022, potential shares totaled 214,400 and shares issued and outstanding totaled 6,488,300, representing 3.3%).」
The potential share ratio declined from 5.0% at the end of the fiscal year to 3.3% at the end of November 2022. - FY2021MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by these stock acquisition rights was 309,600 (excluding potential shares represented by stock acquisition rights whose exercise period expired on 30 September 2021), equivalent to 5.0% of the 6,152,800 shares issued and outstanding.」
Although shares continued to be issued through the exercise of stock acquisition rights, the number of potential shares declined from 596,800 in the previous fiscal year to 309,600, mainly because the Series 1 stock acquisition rights reached the end of their exercise period. Their ratio to total shares issued and outstanding fell from 10.1% to 5.0%. - FY2021-Q3MaterialisedAnnual report
「4 June 2021–17 June 2021 (Note) 4,800 5,911,200 126 238,116 126 238,116」
An additional 4,800 shares were issued through the exercise of stock acquisition rights, bringing total shares issued and outstanding to 5,911,200. The number of shares that could lead to dilution continued to increase. - FY2021-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
From 1 March to 18 March 2021, 17,600 shares were issued through the exercise of stock acquisition rights, increasing total shares issued and outstanding from 5,888,800 to 5,906,400. - FY2020MaterialisedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by stock acquisition rights was 596,800, equivalent to 10.1% of the 5,888,800 shares issued and outstanding.」
New shares were issued through the exercise of stock acquisition rights during the fiscal year, bringing the number of potential shares to 596,800. - FY2020-Q3MaterialisedAnnual report
「In addition, the issuance of new shares through the exercise of stock acquisition rights increased stated capital and the capital surplus by ¥19.403 million each.」
The issuance of new shares through the exercise of stock acquisition rights continued, resulting in an increase in the number of shares from the exercise of potential equity. - FY2020-Q2MaterialisedAnnual report
「In addition, the issuance of new shares through the exercise of stock acquisition rights increased stated capital and the capital surplus by ¥7.272 million each.」
The issuance of new shares through the exercise of stock acquisition rights also occurred during the six-month period ended the second quarter, and the number of shares that could lead to dilution continued to increase. - FY2020-Q1MaterialisedAnnual report
「In addition, the issuance of 23,800 new shares through the exercise of stock acquisition rights on 20 December 2019 increased stated capital and the capital surplus by ¥5.997 million each.」
The exercise of stock acquisition rights resulted in the actual issuance of 23,800 shares, increasing the number of shares through the exercise of potential equity. - FY2019First statedAnnual report
「As of the date of filing this document, the number of potential shares represented by these stock acquisition rights was 282,200, equivalent to 21.1% of the 1,339,200 shares issued and outstanding. If these stock acquisition rights are exercised in the future, the value per share of the Company's equity will be diluted, potentially affecting share price formation.」
The dilution from potential shares represented by stock acquisition rights granted to officers, employees, and others is quantified.